2020
DOI: 10.3390/biom10030481
|View full text |Cite
|
Sign up to set email alerts
|

High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients

Abstract: High concentrations of high-density lipoprotein (HDL) cholesterol are likely associated with a lower risk of posttransplantation diabetes mellitus (PTDM). However, HDL particles vary in size and density with yet unestablished associations with PTDM risk. The aim of our study was to determine the association between different HDL particles and development of PTDM in renal transplant recipients (RTRs). We included 351 stable outpatient adult RTRs without diabetes at baseline evaluation. HDL particle characterist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 66 publications
0
7
0
Order By: Relevance
“…Furthermore, the association between the larger subspecies H6P and H7P and incident T2D were independent of metabolic factors but not of HOMA-IR, triglycerides, and LDL-C. In comparison, we recently documented an inverse association of H6P with development of posttransplantation diabetes in renal transplant recipients ( 22 ).…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…Furthermore, the association between the larger subspecies H6P and H7P and incident T2D were independent of metabolic factors but not of HOMA-IR, triglycerides, and LDL-C. In comparison, we recently documented an inverse association of H6P with development of posttransplantation diabetes in renal transplant recipients ( 22 ).…”
Section: Discussionmentioning
confidence: 92%
“…Lipoprotein parameters were measured by NMR spectroscopy at LabCorp (Morrisville, NC, formerly LipoScience) using an optimized version of the NMR LipoProfile test (LP4 algorithm) on plasma EDTA specimens ( 20 , 22 , 33 ). Total cholesterol, triglycerides, and HDL cholesterol (HDL-C) were measured using Vantera Clinical NMR Analyzer platform using Partial Least-Squares (PLS) regression models.…”
Section: Methodsmentioning
confidence: 99%
“…Lipoprotein parameters were measured by NMR spectroscopy at Labcorp on plasma EDTA specimens [ 43 , 44 , 45 ]. Total cholesterol, HDL-C, triglycerides, apoB, and apoA-I were measured employing the LP4 algorithm [ 29 , 30 , 46 ]. The %CV for apoB ranges from 1.1 to 2.4 and for apoA-I ranges from 1.4 to 2.2.…”
Section: Methodsmentioning
confidence: 99%
“…Despite many studies on lipoprotein abnormalities in severe chronic liver disease, no data have been currently reported concerning nuclear magnetic resonance (NMR)-determined alterations in lipoprotein subfractions in patients with liver cirrhosis or in OLT recipients. Availability of such data is clinically relevant in view of differential associations of LDL, VLDL, and HDL subfractions and particle concentrations with incident atherosclerotic cardiovascular disease and T2D [ 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. Of particular relevance, an abnormal LDL-like lipoprotein, designated Lipoprotein-Z (LP-Z), has been recently characterised using NMR methodology [ 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…Serum creatinine was measured by using an enzymatic isotope dilution assay, traceable on mass spectrometry, on a Roche P-Modulator automated analyzer (Roche Diagnostics, Basel, Switzerland), and kidney function was assessed by using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula for creatinine in order to calculate the estimated glomerular filtration rate (eGFR) [31]. HDL-cholesterol was derived from lipoprotein measures assessed on a Vantera Clinical NMR Analyzer platform [32]. Other serum and urine variables were assessed using standard laboratory methods.…”
Section: Clinical Parametersmentioning
confidence: 99%